Description
A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has certain mutations (changes) in the EGFR gene. It is used in patients whose cancer has not already been treated with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Gefitinib blocks certain proteins made by the EGFR gene, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Gefitinib is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Iressa and ZD1839.
Gefitinib is approved to treat: Non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment in patients whose tumors have certain EGFR gene mutations. Gefitinib is also being studied in the treatment of other types of cancer.
Oncology medicine manufacturer in India
List of Indian Pharma Manufacturer companies name are Astrazeneca, Glenmark, Hetero Healthcare, Cipla, Panacea Biotec, Metta Life Sciences, R.P.G Life Sciences, Bdr Pharmaceuticals, Halsted Pharma
What is the process for submitting order request?
For more information or how to order branded-generic versions “Gefitinib Tablet” manufactured by the pharmaceutical company in India. You can submit an online request or reach us on the given contact details, we will get back to you shortly.
We distribute a diverse range of pharmaceutical drugs, catering to the entirety of the pharmaceutical trade, which includes wholesale, tender supplies, orphan drugs, named patient access, biologics, biosimilars, and vaccines.
FAQs
Is branded-generic versions for Gefitinib Tablet is available in India?
The branded-generic versions for Gefitinib Tablet is available in India through Alleviare. For information on quality, pricing or bulk orders of branded-generic versions manufactured by the pharmaceutical company in India, please send us a message.
What is the price of Gefitinib Tablet in India?
Gefitinib Tablet price in India is reasonable and can vary. To procure Gefitinib Tablet legally, you can call us at 9643240915 (Mr. Yashpal Singh) 9289711087 (Ms. Sana Sadyar), Or Write us at alleviare.exports@gmail.com or sana.sadyar@alleviareindia.com.
Do Alleviare Export Gefitinib Tablet?
Yes Alleviare export Gefitinib Tablet. Alleviare is one of the worldwide supplier of off patented drugs – Gefitinib Tablet. It has wide range of pharma product range, about 15,000 different generic brands across 40 plus therapeutic categories. Alleviare can assist in the delivery of Gefitinib Tablet; the doctor-prescribed medication to the Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), Canada, UAE, Saudi Arabia, Kuwait, Qatar, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Australia, New Zealand, Philippines, the USA, Thailand, China, South Africa, Kazakhstan, Uzbekistan, Hong Kong, Zimbabwe, Zambia, Pakistan, Sri Lanka, Turkey, Afghanistan, Malaysia, Singapore, Japan, Nepal, and many other countries.
What steps should be followed to purchase Gefitinib Tablet from ALS?
If you are looking generic brands for Gefitinib Tablet in India. Please call us at +91 9643240915 (Mr. Yashpal Singh) +91 9289711087 (Ms. Sana Sadyar), Or Write us at alleviare.exports@gmail.com or sana.sadyar@alleviareindia.com. Our support team will be happy to assist you and answer any questions you may have.
Why do generic medicines often cost less than the brand-name medicines?
Generic drugs are approved only after a rigorous review by FDA and after a set period of time that the brand product has been on the market exclusively. This is because new drugs, like other new products, are usually protected by patents that prohibit others from making and selling copies of the same drug.
Generic drugs tend to cost less than their brand-name counterparts because generic drug applicants do not have to repeat animal and clinical (human) studies that were required of the brand-name medicines to demonstrate safety and effectiveness. This abbreviated pathway is why the application is called an “abbreviated new drug application.”
Reference :
www.fda.gov
Where can I find more information about generic medicines?
Contact your doctor, pharmacist, or other health care provider for information on generic medicines. For more information, you can also:
